Congratulations to Precision Medicine Group Co-Founder and CEO Mark Clein on his moderated Point: Counterpoint panel at this year’s HLTH Conference.

“The Science & Politics of Developing a COVID-19 Vaccine & Treatment” featured experts Dr. Helen Boucher (Chief, Division of Geographic Medicine and Infectious Diseases; Chair, Physicians of Tufts Medical Center), Daniel Skovronsky (President Lilly Research Laboratories, Chief Scientific Officer, Eli Lilly and Company), and Tomas Philipson (Former Acting Chair of the White House Council of Economic Advisers; Daniel Levin Chair of Public Policy, University of Chicago)!